Skip to main content
ATEC
NASDAQ Industrial Applications And Services

Alphatec Narrows Loss, Refinances Debt, and Generates Positive Operating Cash Flow

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$9.83
Mkt Cap
$1.592B
52W Low
$6.82
52W High
$23.29
52W Position info
44% above low
Off High info
58% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

ATEC sits 44% above its 52-week low of $6.82.

Summary

Alphatec delivered a much-improved Q2 with revenue up 15% and operating loss nearly eliminated, while refinancing its debt and generating positive operating cash flow. The balance sheet remains fragile with a stockholders' deficit and high leverage.


Key Events · Earnings and Guidance · ATEC

  • Revenue Growth Accelerates

    Driven by increased surgeon adoption and new product launches, Q2 2026 revenue rose 15% YoY to $213.5M. H1 revenue reached $405.6M.

  • Operating Loss Narrows Sharply

    The operating loss improved to $1.9M in Q2 2026 from $13.1M in Q2 2025, as gross margin expanded and litigation costs fell. For the first half, the operating loss was $24.5M versus $57.4M last year.

  • Positive Operating Cash Flow

    Reflecting better working capital management, cash from operations was $21.8M in H1 2026, a significant improvement from $10.5M in H1 2025.

  • Debt Refinancing Completed

    In May 2026, Alphatec entered a new $175M term loan and $125M revolving credit facility with JPMorgan, repaying prior Braidwell and MidCap facilities. The refinancing resulted in an $11.9M loss on debt extinguishment.


Analysis · ATEC · Industrial Applications And Services

A sharp improvement in operating performance marks Alphatec's Q2 results: revenue grew 15% to $213.5M while the operating loss shrank to just $1.9M from $13.1M a year ago. The company also generated $21.8M in cash from operations in the first half, a significant turnaround. Still, the balance sheet remains strained—a $12.1M stockholders' deficit and a $42.1M cash burn in H1, driven by heavy investing and debt refinancing costs. The new JPM credit facilities provide breathing room but add $215M in secured debt. While the subsequent repayment of the 2026 Notes removes a near-term maturity overhang, the company still carries $405M in 2030 convertible notes and must demonstrate sustained cash generation to service its obligations.

At the time of this filing, ATEC was trading at $9.83 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.6B. The 52-week trading range was $6.82 to $23.29. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ATEC - Latest Insights

ATEC
Aug 04, 2026, 4:19 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $9.83
Real-time Price: $9.83 info
Change: $0 (0%) info
Market Cap: $1.592B info
ATEC
Jun 11, 2026, 4:13 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $8.13
Real-time Price: $9.83 info
Change: +$1.70 (+21%) info
Market Cap: $1.592B info
ATEC
May 06, 2026, 1:02 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $7.04
Real-time Price: $9.83 info
Change: +$2.79 (+40%) info
Market Cap: $1.592B info
ATEC
May 05, 2026, 4:56 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $8.15
Real-time Price: $9.83 info
Change: +$1.68 (+21%) info
Market Cap: $1.592B info
ATEC
May 05, 2026, 4:35 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $8.03
Real-time Price: $9.83 info
Change: +$1.80 (+22%) info
Market Cap: $1.592B info